Pharmacies told to stop making custom versions of Wegovy and Zepbound after shortages declared officially over ...

Experts say the tariffs are unlikely to bring back production of generic medicines, given their slim profit margins ...

Levies on Americans’ daily prescriptions and other medicines could raise costs, spur rationing and lead to shortages of ...

The Medicare Rights Center reports that President Trump’s executive order on prescription drug pricing supports key drug ...

An EO signed on April 15th is a solid first step toward improving drug affordability without diminishing the hope of patients ...

The Global Multiple Sclerosis Drugs Market achieved a valuation of $23.2 Billion in 2024 and is anticipated to exceed $53.25 Billion by 2035, reflecting a compounded annual growth rate (CAGR) of 7.85% ...

Quest offers drug testing services and is certified ... currently has the biggest market cap among companies in the cannabis industry. However, other companies with peripheral ties to the industry ...

The Therapeutic Drug Monitoring Market Industry is expected to grow from 5.06 (USD Billion) in 2024 to 9.5 (USD Billion) by 2035. The Therapeutic Drug Monitoring Market CAGR (growth rate ...

U.S. regulators are trying to shut down the industry for compounded weight-loss drugs, which could result in higher costs or ...

In 2024, the FDA's Center for Drug Evaluation and Research (CDER) approved 50 new drugs. The CDER director, Patrizia ...

Stocks in drugmakers sold off globally after President Trump said tariffs on pharmaceutical imports will be unveiled shortly, ...

Explore the impact of proposed Pharma tariffs on global markets as major stocks tumble. Click for my updated look at selected picks in the health industry.